{"count":13,"docs":"https://aiswingx.com/docs","items":[{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/RevenueFromContractWithCustomerExcludingAssessedTax","change":0.06873505831385135,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Revenue","label_en":"Revenue","label_ko":"\ub9e4\ucd9c","period_type":"duration","xbrl_tag":"RevenueFromContractWithCustomerExcludingAssessedTax"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/RevenueFromContractWithCustomerExcludingAssessedTax","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-33","unit":"USD","value":80915000.0,"xbrl_fact_id":"f-33"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-34","unit":"USD","value":75711000.0,"xbrl_fact_id":"f-34"}],"statement":"AngioDynamics, Inc. (ANGO) reported Revenue of USD 80,915,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/RevenueFromContractWithCustomerExcludingAssessedTax","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-33"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/GrossProfit","change":0.14771722770384882,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Gross profit","label_en":"Gross profit","label_ko":"\ub9e4\ucd9c\ucd1d\uc774\uc775","period_type":"duration","xbrl_tag":"GrossProfit"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/GrossProfit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-37","unit":"USD","value":48040000.0,"xbrl_fact_id":"f-37"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-38","unit":"USD","value":41857000.0,"xbrl_fact_id":"f-38"}],"statement":"AngioDynamics, Inc. (ANGO) reported Gross profit of USD 48,040,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/GrossProfit","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-37"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/OperatingIncomeLoss","change":0.31475225225225223,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Operating income","label_en":"Operating income","label_ko":"\uc601\uc5c5\uc774\uc775","period_type":"duration","xbrl_tag":"OperatingIncomeLoss"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/OperatingIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-51","unit":"USD","value":-7302000.0,"xbrl_fact_id":"f-51"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-52","unit":"USD","value":-10656000.0,"xbrl_fact_id":"f-52"}],"statement":"AngioDynamics, Inc. (ANGO) reported Operating income of USD -7,302,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/OperatingIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-51"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/NetIncomeLoss","change":0.34907823534806937,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Net income","label_en":"Net income","label_ko":"\uc21c\uc774\uc775","period_type":"duration","xbrl_tag":"NetIncomeLoss"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/NetIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-63","unit":"USD","value":-7097000.0,"xbrl_fact_id":"f-63"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-64","unit":"USD","value":-10903000.0,"xbrl_fact_id":"f-64"}],"statement":"AngioDynamics, Inc. (ANGO) reported Net income of USD -7,097,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/NetIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-63"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/IncomeTaxExpenseBenefit","change":-4.061538461538461,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Income tax","label_en":"Income tax","label_ko":"\ubc95\uc778\uc138","period_type":"duration","xbrl_tag":"IncomeTaxExpenseBenefit"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/IncomeTaxExpenseBenefit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-61","unit":"USD","value":-199000.0,"xbrl_fact_id":"f-61"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-62","unit":"USD","value":65000.0,"xbrl_fact_id":"f-62"}],"statement":"AngioDynamics, Inc. (ANGO) reported Income tax of USD -199,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/IncomeTaxExpenseBenefit","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-61"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/ShareBasedCompensation","change":0.0071588366890380315,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Stock-based compensation","label_en":"Stock-based compensation","label_ko":"\uc8fc\uc2dd\ubcf4\uc0c1","period_type":"duration","xbrl_tag":"ShareBasedCompensation"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/ShareBasedCompensation","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-163","unit":"USD","value":4502000.0,"xbrl_fact_id":"f-163"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-164","unit":"USD","value":4470000.0,"xbrl_fact_id":"f-164"}],"statement":"AngioDynamics, Inc. (ANGO) reported Stock-based compensation of USD 4,502,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/ShareBasedCompensation","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-163"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/NetCashProvidedByUsedInOperatingActivities","change":0.03669724770642202,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-181","unit":"USD","value":-15330000.0,"xbrl_fact_id":"f-181"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-182","unit":"USD","value":-15914000.0,"xbrl_fact_id":"f-182"}],"statement":"AngioDynamics, Inc. (ANGO) reported Operating cash flow of USD -15,330,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-181"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/PaymentsToAcquirePropertyPlantAndEquipment","change":-0.48153214774281805,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Capex","label_en":"Capex","label_ko":"\uc124\ube44\ud22c\uc790","period_type":"duration","xbrl_tag":"PaymentsToAcquirePropertyPlantAndEquipment"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/PaymentsToAcquirePropertyPlantAndEquipment","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-08-31","period_start":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-183","unit":"USD","value":379000.0,"xbrl_fact_id":"f-183"},{"comparative":true,"instant":false,"period_end":"2025-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-184","unit":"USD","value":731000.0,"xbrl_fact_id":"f-184"}],"statement":"AngioDynamics, Inc. (ANGO) reported Capex of USD 379,000 for the period from 2026-06-01 to 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/PaymentsToAcquirePropertyPlantAndEquipment","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-183"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/AccountsReceivableNetCurrent","change":-0.07077082255561304,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Accounts receivable","label_en":"Accounts receivable","label_ko":"\ub9e4\ucd9c\ucc44\uad8c","period_type":"instant","xbrl_tag":"AccountsReceivableNetCurrent"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/AccountsReceivableNetCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-89","unit":"USD","value":44905000.0,"xbrl_fact_id":"f-89"},{"comparative":true,"instant":true,"period_end":"2026-05-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-90","unit":"USD","value":48325000.0,"xbrl_fact_id":"f-90"}],"statement":"AngioDynamics, Inc. (ANGO) reported Accounts receivable of USD 44,905,000 as of 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/AccountsReceivableNetCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-89"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/InventoryNet","change":0.0480013731024487,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Inventory","label_en":"Inventory","label_ko":"\uc7ac\uace0","period_type":"instant","xbrl_tag":"InventoryNet"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/InventoryNet","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-91","unit":"USD","value":54953000.0,"xbrl_fact_id":"f-91"},{"comparative":true,"instant":true,"period_end":"2026-05-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-92","unit":"USD","value":52436000.0,"xbrl_fact_id":"f-92"}],"statement":"AngioDynamics, Inc. (ANGO) reported Inventory of USD 54,953,000 as of 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/InventoryNet","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-91"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/CashAndCashEquivalentsAtCarryingValue","change":-0.36928189514332393,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Cash","label_en":"Cash","label_ko":"\ud604\uae08","period_type":"instant","xbrl_tag":"CashAndCashEquivalentsAtCarryingValue"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/CashAndCashEquivalentsAtCarryingValue","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-85","unit":"USD","value":33973000.0,"xbrl_fact_id":"f-85"},{"comparative":true,"instant":true,"period_end":"2026-05-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-86","unit":"USD","value":53864000.0,"xbrl_fact_id":"f-86"}],"statement":"AngioDynamics, Inc. (ANGO) reported Cash of USD 33,973,000 as of 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/CashAndCashEquivalentsAtCarryingValue","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-85"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/Assets","change":-0.0944367296369632,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Total assets","label_en":"Total assets","label_ko":"\ucd1d\uc790\uc0b0","period_type":"instant","xbrl_tag":"Assets"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/Assets","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-103","unit":"USD","value":241933000.0,"xbrl_fact_id":"f-103"},{"comparative":true,"instant":true,"period_end":"2026-05-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-104","unit":"USD","value":267163000.0,"xbrl_fact_id":"f-104"}],"statement":"AngioDynamics, Inc. (ANGO) reported Total assets of USD 241,933,000 as of 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/Assets","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-103"},{"accession":"0001628280-26-065423","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0001628280-26-065423/StockholdersEquity","change":-0.04016976437875018,"cik":1275187,"company":"AngioDynamics, Inc.","concept":{"label":"Total equity","label_en":"Total equity","label_ko":"\uc790\uae30\uc790\ubcf8","period_type":"instant","xbrl_tag":"StockholdersEquity"},"filed_at":"2026-10-08","filing_index_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/0001628280-26-065423-index.htm","filing_url":"https://aiswingx.com/f/0001628280-26-065423","form":"10-Q","id":"0001628280-26-065423/StockholdersEquity","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-08-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-151","unit":"USD","value":163963000.0,"xbrl_fact_id":"f-151"},{"comparative":true,"instant":true,"period_end":"2026-05-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-152","unit":"USD","value":170825000.0,"xbrl_fact_id":"f-152"}],"statement":"AngioDynamics, Inc. (ANGO) reported Total equity of USD 163,963,000 as of 2026-08-31 in its 10-Q (accession 0001628280-26-065423, filed 2026-10-08).","ticker":"ANGO","url":"https://aiswingx.com/n/0001628280-26-065423/StockholdersEquity","verify_url":"https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/ango-20260831.htm#f-151"}],"limit":100,"note":"Inline XBRL facts as filed with the SEC, each with a permanent citation URL and a deep link to the figure in the filing document.","offset":0,"total":13}